Valuation (19%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -43.12 | -23.37 |
PEG Ratio (TTM) | 1.01 | -7.10 |
P/S Ratio (TTM) | 176,909.93 | 44.34 |
P/B Ratio (TTM) | 7.13 | 33.03 |
P/FCF Ratio (TTM) | -43.06 | -7.73 |
Price to 5YR AVG Earnings Ratio | N/A | -7.08 |
Price to 5YR AVG FCF Ratio | N/A | -13.02 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -15.59% | -15.67% |
ROE (TTM) | -15.78% | 27.44% |
Net Profit Margin (TTM) | -409,200.94% | -627.99% |
ROIC 5YR AVG | N/A | -4.84% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -42.72% | -37,298.83% | N/A |
Revenue | -25.00% | N/A | N/A |
Net Income | -46.52% | -19,643.41% | N/A |
Cash Flow | -32.94% | -3,680.83% | N/A |
Health (49%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 25.51 | 5.66 |
Quick Ratio (TTM) | 25.51 | 5.44 |
D/E Ratio (TTM) | N/A | 1.19 |
Interest Coverage (TTM) | N/A | -5.92 |
Piotroski F-Score | 2 | 5 |
Altman Z-Score | 92.36 | 13.21 |
LTL to 5YR AVG FCF | N/A | 0.09 |
Shares Outstanding Growth 5YR AVG | N/A | 39.51% |